These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
349 related items for PubMed ID: 23384436
21. Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Kiupel M, Webster JD, Bailey KL, Best S, DeLay J, Detrisac CJ, Fitzgerald SD, Gamble D, Ginn PE, Goldschmidt MH, Hendrick MJ, Howerth EW, Janovitz EB, Langohr I, Lenz SD, Lipscomb TP, Miller MA, Misdorp W, Moroff S, Mullaney TP, Neyens I, O'Toole D, Ramos-Vara J, Scase TJ, Schulman FY, Sledge D, Smedley RC, Smith K, W Snyder P, Southorn E, Stedman NL, Steficek BA, Stromberg PC, Valli VE, Weisbrode SE, Yager J, Heller J, Miller R. Vet Pathol; 2011 Jan; 48(1):147-55. PubMed ID: 21062911 [Abstract] [Full Text] [Related]
22. Prevalence and prognostic value of c-kit and TP53 mutations in canine mast cell tumours. Vozdova M, Kubickova S, Fictum P, Fröhlich J, Jelinek F, Rubes J. Vet J; 2019 May; 247():71-74. PubMed ID: 30971355 [Abstract] [Full Text] [Related]
23. Overexpression of P-glycoprotein, STAT3, phospho-STAT3 and KIT in spontaneous canine cutaneous mast cell tumours before and after prednisolone treatment. Teng SP, Hsu WL, Chiu CY, Wong ML, Chang SC. Vet J; 2012 Aug; 193(2):551-6. PubMed ID: 22398132 [Abstract] [Full Text] [Related]
24. Cytological grading of canine cutaneous mast cell tumours. Scarpa F, Sabattini S, Bettini G. Vet Comp Oncol; 2016 Sep; 14(3):245-51. PubMed ID: 24717019 [Abstract] [Full Text] [Related]
25. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers. Gil da Costa RM, Matos E, Rema A, Lopes C, Pires MA, Gärtner F. BMC Vet Res; 2007 Aug 21; 3():19. PubMed ID: 17711582 [Abstract] [Full Text] [Related]
27. Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours. Giuliano A, Dos Santos Horta R, Constantino-Casas F, Hoather T, Dobson J. J Comp Pathol; 2017 Jan 21; 156(1):14-20. PubMed ID: 27889201 [Abstract] [Full Text] [Related]
28. Prognostic and predictive significance of KIT protein expression and c-kit gene mutation in canine cutaneous mast cell tumours: A consensus of the Oncology-Pathology Working Group. Thamm DH, Avery AC, Berlato D, Bulman-Fleming J, Clifford CA, Hershey AE, Intile JL, Jones PD, Kamstock DA, Liptak JM, Pavuk A, Peauroi J, Powell R, Rissetto K, Valli VEO, Webster JD. Vet Comp Oncol; 2019 Dec 21; 17(4):451-455. PubMed ID: 31264352 [Abstract] [Full Text] [Related]
30. Differences in the proteome of high-grade versus low-grade canine cutaneous mast cell tumours. Schlieben P, Meyer A, Weise C, Bondzio A, Einspanier R, Gruber AD, Klopfleisch R. Vet J; 2012 Nov 21; 194(2):210-4. PubMed ID: 22578690 [Abstract] [Full Text] [Related]
36. Comparison of mitotic index and Ki67 index in the prognostication of canine cutaneous mast cell tumours. Berlato D, Murphy S, Monti P, Stewart J, Newton JR, Flindall A, Maglennon GA. Vet Comp Oncol; 2015 Jun 21; 13(2):143-50. PubMed ID: 23489679 [Abstract] [Full Text] [Related]
38. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication. Webster JD, Yuzbasiyan-Gurkan V, Miller RA, Kaneene JB, Kiupel M. Vet Pathol; 2007 May 21; 44(3):298-308. PubMed ID: 17491070 [Abstract] [Full Text] [Related]